Dipyridamole thallium imaging may not be a reliable screening test for coronary artery disease in patients undergoing vascular surgery
Key result
Dipyridamole SPECT thallium imaging failed to identify 7 of 10 patients with perioperative coronary events, showing poor predictive accuracy for routine preoperative risk stratification.
Why the study?
Does preoperative dipyridamole thallium imaging reliably predict perioperative coronary events in patients undergoing vascular surgery?
Population
86 patients undergoing vascular surgery procedures
Comparison
Preoperative dipyridamole SPECT thallium imaging vs Preoperative clinical assessment
Design
Cohort
Follow-up
perioperative
Authors
Discussion
Loading...
Member takes
Implication
Does not support routine preoperative use; leaves open the need for validated alternatives in vascular surgery patients.
Study Design
Type
Cohort (n=86)
Multicenter
No
Structured PICO
Does preoperative dipyridamole thallium imaging reliably predict perioperative coronary events in patients undergoing vascular surgery?
P
Population
86 patients undergoing vascular surgery procedures evaluated for perioperative coronary events using preoperative clinical assessment and dipyridamole SPECT thallium imaging.
E
Exposure
Preoperative dipyridamole SPECT thallium imaging (DST)
C
Comparator
Preoperative clinical assessment
O
Outcome
Perioperative coronary event (unstable angina, myocardial infarction, or cardiac death)hard clinical
Main Result
Absolute Event Rate: 16% vs 14%
Dipyridamole thallium imaging is not an ideal routine noninvasive technique for preoperative cardiac risk stratification in patients undergoing vascular surgery, as it failed to identify the majority of patients who suffered perioperative coronary events.
Limitations
- Application of the test to a low to moderate risk population may have lowered its predictive accuracy for coronary events.
- Application of the test to a low to moderate risk population may be responsible for its lower predictive accuracy
Cite This Study
Marwick et al. (1990) conducted a cohort in Peripheral vascular surgery (n=86). Dipyridamole SPECT thallium imaging (DST) vs. Preoperative clinical assessment was evaluated on Perioperative coronary event (unstable angina, myocardial infarction, or cardiac death). Dipyridamole SPECT thallium imaging failed to identify 7 of 10 patients with perioperative coronary events, showing poor predictive accuracy for routine preoperative risk stratification.